Grantham, Mayo, Van Otterloo & Co (GMO)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-115,084
| Closed | -$754K | – | 858 |
|
|
2020
Q4 | $754K | Sell |
115,084
-110,416
| -49% | -$723K | ﹤0.01% | 611 |
|
|
2020
Q3 | $1.5M | Buy |
225,500
+74,000
| +49% | +$492K | 0.01% | 457 |
|
|
2020
Q2 | $1.26M | Buy |
151,500
+132,500
| +697% | +$1.1M | 0.01% | 495 |
|
|
2020
Q1 | $146K | Buy |
+19,000
| New | +$146K | ﹤0.01% | 714 |
|
|
2018
Q3 | – | Sell |
-14,900
| Closed | -$341K | – | 534 |
|
|
2018
Q2 | $341K | Hold |
14,900
| – | – | ﹤0.01% | 484 |
|
|
2018
Q1 | $424K | Hold |
14,900
| – | – | ﹤0.01% | 479 |
|
|
2017
Q4 | $315K | Buy |
+14,900
| New | +$315K | ﹤0.01% | 495 |
|